ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
Dow Jones
43.297,03
0,91%
Euro vs US Dollar
1,04305
0,26%
Bitcoin
98.409,19
-0,27%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Q32 Bio Inc (QTTB)

  7. Q32 Bio Inc (QTTB) News

QTTB

Q32 Bio (QTTB)

Q32 Bio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:QTTB
DatumZeitQuelleÜberschriftSymbolFirma
11/12/202413h07Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
11/12/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTTBQ32 Bio Inc
10/12/202422h05PR Newswire (US)Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development ProgramNASDAQ:QTTBQ32 Bio Inc
07/11/202413h28Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
07/11/202413h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QTTBQ32 Bio Inc
07/11/202413h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTTBQ32 Bio Inc
07/11/202412h59PR Newswire (US)Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:QTTBQ32 Bio Inc
05/11/202412h59PR Newswire (US)Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation ConferenceNASDAQ:QTTBQ32 Bio Inc
17/10/202402h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
14/10/202412h59PR Newswire (US)Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024NASDAQ:QTTBQ32 Bio Inc
10/10/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
28/09/202403h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
28/09/202403h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
28/09/202403h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
28/09/202403h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
29/08/202412h59PR Newswire (US)Q32 Bio to Participate in Upcoming September Investor ConferencesNASDAQ:QTTBQ32 Bio Inc
14/08/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTTBQ32 Bio Inc
08/08/202413h18Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
08/08/202413h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QTTBQ32 Bio Inc
08/08/202413h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTTBQ32 Bio Inc
09/07/202413h15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
09/07/202413h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTTBQ32 Bio Inc
09/07/202412h59PR Newswire (US)Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic DermatitisNASDAQ:QTTBQ32 Bio Inc
01/07/202412h59PR Newswire (US)Q32 Bio Joins Russell 3000® IndexNASDAQ:QTTBQ32 Bio Inc
31/05/202422h25Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:QTTBQ32 Bio Inc
09/05/202413h26Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QTTBQ32 Bio Inc
09/05/202413h18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QTTBQ32 Bio Inc
09/05/202413h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTTBQ32 Bio Inc
09/05/202412h59PR Newswire (US)Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:QTTBQ32 Bio Inc
03/04/202413h00PR Newswire (US)Q32 Bio Appoints Lee Kalowski as President & Chief Financial OfficerNASDAQ:QTTBQ32 Bio Inc
 Showing the most relevant articles for your search:NASDAQ:QTTB

Kürzlich von Ihnen besucht

USOTC
BASFY
BASF (QX)
NASDAQ
MSFT
Microsoft
COIN
ETHUSD
Ethereum
FX
EURUSD
Euro vs US Dollar
USOTC
RHHBY
Roche (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
SPY
SPDR S&P 500
FX
EURGBP
Euro vs Sterling
NYSE
MCD
McDonalds
CCOM
US500
US 500
TG
LHA
Deutsche Lufthansa
PM
XAUUSD
Gold vs US Dollar
TG
MBG
MercedesBenz
NYSE
XOM
Exxon Mobil
NYSE
MRK
Merck
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten